OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
August 01, 2022
Manufacturers are taking the first steps toward process intensification.
May 09, 2022
MilliporeSigma’s ZooMAb antibodies have been recognized for their low environmental impact by My Green Lab.
April 01, 2022
The past year of downstream processing has brought innovations in pH sensitive antibody purification, single-use fermentation separators, and more.
October 04, 2021
Thermo Fisher’s new Swiss facility will initially produce CSL Limited’s recombinant factor IX product Idelvion.
March 15, 2021
WuXi will produce SARS-CoV-2 s-proteins for BioVaxys’ COVID-19 vaccine candidate, BVX-0320, and for its Covid-T immunodiagnostic program.
February 17, 2021
The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.
December 02, 2020
The grant will support the advancement of glycoengineering technology for plant-derived proteins developed by a University of Alberta scientist partnered with PlantForm.
October 11, 2018
The new facility will include comprehensive mammalian process development and manufacturing capabilities.
July 01, 2018
Increasing demand for biologics is driving the need for innovation in bioprocessing.
April 11, 2018
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.